DIAZOXIDE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. (Chemical Entities of Biological Interest Ontology, CHEBI_4495)
External Link https://dgidb.org/results?searchType=drug&searchTerms=DIAZOXIDE
Similar Terms
Downloads & Tools

Genes

13 interacting proteins for the DIAZOXIDE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
CCK cholecystokinin 2.71446
SNAP25 synaptosomal-associated protein, 25kDa 0.740308
CYP7B1 cytochrome P450, family 7, subfamily B, polypeptide 1 0.542892
KCNJ8 potassium channel, inwardly rectifying subfamily J, member 8 0.508961
SLC12A3 solute carrier family 12 (sodium/chloride transporter), member 3 0.45241
NT5E 5'-nucleotidase, ecto (CD73) 0.290835
LPL lipoprotein lipase 0.254481
NOS2 nitric oxide synthase 2, inducible 0.220091
CALCA calcitonin-related polypeptide alpha 0.162868
KCNJ11 potassium channel, inwardly rectifying subfamily J, member 11 0.123385
CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2 0.00697207
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 0.00666398
EHMT2 euchromatic histone-lysine N-methyltransferase 2 0.00465869